Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Impact of Climate Change

Vanessa Caceres  |  July 29, 2024

When trying to pinpoint the connection to climate because it may exacerbate rheumatic conditions, Dr. Dellaripa said that immune system changes and epigenetic effects may be caused by exposure to heat, wildfire and other climate effects.

“That’s where we don’t know enough yet. … That’s where the gap in our knowledge is at this point and [what] future investigations need to be focused [on],” he said.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Climate Research

Dr. Dellaripa shared some experiences that sparked his interest in climate change and how it relates to rheumatology. More than 10 years ago, he was caring for a hospital patient who had returned from Australia after being exposed to a wildfire there that exacerbated her asthma and forced her to leave. Upon her return to Boston, she was hospitalized due to severe respiratory distress.

He also saw patients presenting with interstitial lung disease (ILD) closely after exposure to a wildfire in California.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“I couldn’t conclude clear causation between their exposure and the development of their autoimmune ILD, but it did raise the question of whether smoke due to wildfires may have played a role in the development of their disease.”  Another possibility: “Patients with pre-existing rheumatic diseases may worsen with such exposures,” he said.

Dr. Dellaripa brought his concerns and research on the topic to the ACR, which formed a study group. This led to the publication of a white paper on the effects of climate change on rheumatic conditions published earlier this year.4

After analyzing 88 articles, the study team behind the white paper found that increased heat vulnerability was associated with higher odds of recurrent hospitalizations across rheumatic conditions and that air pollution was associated with an increased risk of rheumatoid arthritis (RA), gout flares and hospitalizations for systemic lupus erythematosus. Although exact causes remain unknown, the study team suggested these findings could be related to epigenetic changes, oxidative stress and inflammatory cytokines.4

More research needs to be conducted, and other disciplines, such as allergy, cardiology pulmonary and nephrology, are further ahead of rheumatology in this type of research, Dr. Dellaripa noted. However, he believes the research will continue to move forward in rheumatology with the support of professional societies, patient support groups and federal efforts. 

Future research should also include a focus on how climate change has affected those who are traditionally marginalized, Dr. Hausmann says.

Dr. Dellaripa pointed to heat exposure research he was involved with that showed a significant overlap between those areas with the highest level of heat and social vulnerability.5 

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR on Airair pollutionclimate changeRheumatic Disease

Related Articles

    A World of Difference: Updates from the Global Rheumatology Summit

    January 20, 2023

    The second annual Global Rheumatology Summit focused on climate change, conflict and migration, as well as other global issues in rheumatology.

    Air Pollution: Is There an Association with Rheumatic Disease?

    December 17, 2015

    Interactions between an individual’s genetic background and their exposure to environmental factors are thought to result in a cascade of immune reactions, ultimately leading to the development of autoimmune diseases such as rheumatoid arthritis (RA), juvenile idiopathic arthritis (JIA), systemic lupus erythematosus (SLE) and juvenile dermatomyositis.1,2 For example, an environmental factor that conclusively affects susceptibility…

    Dual-Trained Rheumatologists Take Multidisciplinary Approach to Their Patients

    October 14, 2015

    Co-morbidities in patients with rheumatoid arthritis and related autoimmune diseases often warrant a multidisciplinary approach to treatment. When it comes to inflammatory and fibrotic lung conditions in these patients, collaboration between pulmonary/critical care specialists and rheumatologists is essential, say two rheumatologists recently interviewed by The Rheumatologist. Both followed their rheumatology fellowship training with additional fellowships…

    Oksana Shufrych TKTK / Shutterstock.com

    Heated Gloves May Improve Hand Function in Diffuse Systemic Sclerosis

    October 16, 2017

    Systemic sclerosis (SSc), a subtype of scleroderma, is a rare, complex autoimmune disease characterized by widespread vasculopathy of the small arteries and fibroblast dysfunction.1,2 It has been described as a fibrosing micro­vascular disease, because vascular injury precedes and leads to tissue fibrosis.3 The resulting Raynaud’s phenomenon, pain, skin thickening and tightening, and multi-organ involvement have…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences